IHP Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $35M

  • Investors
  • 6

IHP Therapeutics General Information

Description

Developer of novel medicines designed to improve and save lives through scientific discovery and the development of glycan therapeutics. The company develops novel pipeline compounds and clinical-stage drugs and its clinical-stage compound is a glycan new chemical entity with anticoagulant, anti-inflammatory and antiviral activity, enabling healthcare professionals to treat their patients suffering from cancer and hemolytic diseases.

Contact Information

Website
www.ihptherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 930 Brittan Avenue
  • San Carlos, CA 94070
  • United States
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • 930 Brittan Avenue
  • San Carlos, CA 94070
  • United States

IHP Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

IHP Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Early Stage VC (Series A) 31-Oct-2024 $35M Completed Product Development
7. Accelerator/Incubator 01-Jan-2024 Completed Product Development
6. Accelerator/Incubator Completed Product Development
5. Grant 05-Mar-2023 Completed Product Development
4. Grant 01-Jan-2023 Completed Product Development
3. Grant 31-Dec-2022 Completed Product Development
2. Accelerator/Incubator 03-Aug-2022 $1.7M Completed Product Development
1. Seed Round 18-Jul-2022 $1.7M $1.7M Completed Product Development
To view IHP Therapeutics’s complete valuation and funding history, request access »

IHP Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed
To view IHP Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

IHP Therapeutics Patents

  • 11

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 7

    Pending

  • Expiring in next 12 mo

IHP Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023282822-A1 Chemically modified heparin Pending 06-Jun-2022
EP-4536248-A1 Chemically modified heparin Pending 06-Jun-2022
EP-4536248-A4 Chemically modified heparin Pending 06-Jun-2022
EP-4536745-A1 Chemically modified heparin Pending 06-Jun-2022
EP-4536745-A4 Chemically modified heparin Pending 06-Jun-2022 A61K31/727
To view IHP Therapeutics’s complete patent history, request access »

IHP Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

IHP Therapeutics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
California Life Sciences Accelerator/Incubator
National Institutes of Health Government
Small Business Innovation Research and Small Business Technology Transfer Programs Government
United States Department of War Government
TechQuity Accelerator Accelerator/Incubator
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

IHP Therapeutics FAQs

  • When was IHP Therapeutics founded?

    IHP Therapeutics was founded in 2020.

  • Where is IHP Therapeutics headquartered?

    IHP Therapeutics is headquartered in San Carlos, CA.

  • What is the size of IHP Therapeutics?

    IHP Therapeutics has 8 total employees.

  • What industry is IHP Therapeutics in?

    IHP Therapeutics’s primary industry is Drug Discovery.

  • Is IHP Therapeutics a private or public company?

    IHP Therapeutics is a Private company.

  • What is IHP Therapeutics’s current revenue?

    The current revenue for IHP Therapeutics is .

  • How much funding has IHP Therapeutics raised over time?

    IHP Therapeutics has raised $36.7M.

  • Who are IHP Therapeutics’s investors?

    California Life Sciences, National Institutes of Health, Small Business Innovation Research and Small Business Technology Transfer Programs, United States Department of War, and TechQuity Accelerator are 5 of 6 investors who have invested in IHP Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process